OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

Q: What does CUSIP 67576A100 represent in this 13F holders report?

CUSIP 67576A100 is the security identifier for OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in Q2 2018?

69 institutional investors reported OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 67576A100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 218,782,791
Total 13F shares: 22,017,576
Share change: +1,441,774
Total reported value: $148,575,866
Put/Call ratio: 36%
Price per share: $6.75
Number of holders: 69
Value change: +$9,801,776
Number of buys: 39
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 67576A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.5%	3,239,448	$21,089,000	—	31 Mar 2018	13F
SUMMER ROAD LLC	13F	Company	1.4%	3,027,488	$19,709,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	1%	2,292,752	$14,926,000	—	31 Mar 2018	13F
Versant Venture Management, LLC	13F	Company	1%	2,215,384	$14,422,150	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.78%	1,696,612	$11,046,000	—	31 Mar 2018	13F
SV Health Investors, LLC	13F	Company	0.73%	1,605,207	$10,449,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.66%	1,449,865	$9,439,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.61%	1,344,541	$8,753,000	—	31 Mar 2018	13F
DELTEC ASSET MANAGEMENT LLC	13F	Company	0.27%	586,239	$3,816,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.17%	373,923	$2,439,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.15%	324,526	$2,112,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.12%	272,155	$1,772,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.11%	234,545	$1,526,000	—	31 Mar 2018	13F
Atika Capital Management LLC	13F	Company	0.1%	220,000	$1,432,000	—	31 Mar 2018	13F
Endurant Capital Management LP	13F	Company	0.08%	178,461	$1,162,000	—	31 Mar 2018	13F
NOTTINGHAM ADVISORS, INC.	13F	Company	0.07%	146,946	$957,000	—	31 Mar 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	103,300	$672,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.04%	83,018	$541,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	81,868	$533,000	—	31 Mar 2018	13F
Hikari Power Ltd	13F	Company	0.04%	80,011	$521,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	71,087	$463,000	—	31 Mar 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	61,474	$400,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	53,570	$349,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	44,400	$289,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	43,920	$286,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	43,124	$281,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.02%	42,679	$278,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	42,369	$276,000	—	31 Mar 2018	13F
NewEdge Advisors, LLC	13F	Company	0.02%	41,250	$266,000	—	31 Mar 2018	13F
Neuberger Berman Group LLC	13F	Company	0.02%	39,165	$255,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	37,728	$243,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	0.02%	35,406	$230,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	33,483	$218,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.01%	28,233	$184,000	—	31 Mar 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	27,375	$178,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	24,123	$157,000	—	31 Mar 2018	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	22,947	$149,000	—	31 Mar 2018	13F
Virtu Financial LLC	13F	Company	0.01%	20,139	$131,000	—	31 Mar 2018	13F
ELLINGTON MANAGEMENT GROUP LLC	13F	Company	0.01%	20,100	$131,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	18,600	$121,000	—	31 Mar 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	18,434	$120,000	—	31 Mar 2018	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	18,000	$117,000	—	31 Mar 2018	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	15,600	$102,000	—	31 Mar 2018	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.01%	11,310	$74,000	—	31 Mar 2018	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	10,979	$71,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0%	8,448	$55,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0%	7,500	$49,000	—	31 Mar 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	6,407	$41,710	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	5,805	$38,000	—	31 Mar 2018	13F
Legal & General Group Plc	13F	Company	0%	5,083	$33,000	—	31 Mar 2018	13F

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q2 2018

As of 30 Jun 2018, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,017,576 shares. The largest 10 holders included FMR LLC, SUMMER ROAD LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, SV Health Investors, LLC, Opaleye Management Inc., and DELTEC ASSET MANAGEMENT LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.